AVH and RCEL Related Headlines
Go Back- AVITA Medical to Announce Second Quarter 2026 Financial Results
- AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports First Quarter 2026 Financial Results
- AVITA Medical appoints Cary Vance as permanent CEO
- AVITA Medical Names Cary Vance as Chief Executive Officer
- AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
- AVITA Medical to Announce First Quarter 2026 Financial Results
- AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
- AVITA Medical reports faster wound healing times in Cohealyx study
- AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
- AVITA Medical signs $25.5M emergency preparedness deal with BARDA
- AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
- AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
- AVITA Medical adds healthcare executive to board, chairman retires
- AVITA Medical Announces Changes to its Board of Directors
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA® Medical Reports Third Quarter 2025 Financial Results
- Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
- AVITA Medical to Announce Third Quarter 2025 Financial Results
- AVITA Medical Welcomes Support for RECELL® in Burns in Australia
- AVITA Medical names board chairman as interim CEO
- AVITA Medical Announces CEO Transition
- CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
- AVITA Medical receives CE mark for RECELL GO device in Europe
- AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
- Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
- AVITA Medical Announces September Investor Conference Participation
- AVITA Medical Successfully Completes Australian Equity Raise
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
- AVITA Medical names Michael Tarnoff to board, Cary Vance as chair
- AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
AVH and RCEL Related Press Releases
Go Back- AVITA Medical to Announce Second Quarter 2026 Financial Results
- AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports First Quarter 2026 Financial Results
- AVITA Medical Names Cary Vance as Chief Executive Officer
- AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
- AVITA Medical to Announce First Quarter 2026 Financial Results
- AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
- AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
- AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
- AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
- AVITA Medical Announces Changes to its Board of Directors
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA® Medical Reports Third Quarter 2025 Financial Results
- Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
- AVITA Medical to Announce Third Quarter 2025 Financial Results
- AVITA Medical Welcomes Support for RECELL® in Burns in Australia
- AVITA Medical Announces CEO Transition
- CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
- AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
- Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
- AVITA Medical Announces September Investor Conference Participation
- AVITA Medical Successfully Completes Australian Equity Raise
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
- AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
